TABLE 1.
Imaging techniques | Cancer | Viruses | Genes | Results |
Bioluminescence imaging (27) | Breast cancer | Herpes simplex virus, Herpes simplex virus-1, Herpes simplex virus-Luc | Luciferase | Viral replication cycles can be monitored by bioluminescence imaging |
Fluorescence imaging (28) | Breast cancer | Vaccinia virus, Lister strain GLV 1h153 | Green fluorescent protein | All positive surgical margins can be observed through FI by the infection of GLV-1h153 |
SPECT/CT (29) | Prostate cancer | Adenovirus serotype, adenovirus serotype 5, adenovirus serotype 5-yCD/mutTKSR3 9rep-hNIS | Human Na+/I- symporter gene | Tumor imaging was detected in seven of nine (78%) patients |
PET (30) | Gastric cancer | Vaccinia virus, Lister strain, GLV-1h153 | Human Na+/I- symporter gene | Tumor imaging can be visualized through 99mTc pertechnetate SPECT and 124I PET by the infection of hNIS expressing GLV-1h153 |
MRI (31) | Prostate tumor | Vaccinia virus, Lister strain, GLV-1h68, GLV-1h312, GLV-1h460, GLV-1h462 | Tyrosinase, Tyrosinase p1, Tyrosinase p2, Melanin | The tumor signal enhancement of MRI can be detected after infection of GLV-1h462. The expression of melanin can be controlled by the doxycycline inducible promoter-system and thereby decrease inhibition of viral replication due to melanin overproduction |
GLV, green fluorescent protein-expressing vaccinia virus.